Ras signaling pathway modulators (KHR Biotech/Indivumed)

N/A

Report date: 2025/03/20 10:05:47
NME

Base Information

Drug NameRas signaling pathway modulators (KHR Biotech/Indivumed)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGTPase Ras modulators
TargetsGTPase Ras
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKHR Biotec GmbH
China Registration ClassN/A

Develop Information

Active CompaniesKHR Biotec GmbHIndivumed GmbH
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A